BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a large decline in short interest in September. As of September 15th, there was short interest totaling 126,688 shares, a decline of 57.3% from the August 31st total of 296,445 shares. Based on an average trading volume of 188,153 shares, the short-interest ratio is currently 0.7 days. Approximately 0.1% of the company’s stock are sold short.

BetterLife Pharma Trading Down 9.1%

Shares of OTCMKTS BETRF traded down $0.02 during mid-day trading on Monday, reaching $0.22. The company had a trading volume of 49,216 shares, compared to its average volume of 90,539. BetterLife Pharma has a twelve month low of $0.03 and a twelve month high of $0.33. The stock’s 50 day moving average is $0.22 and its 200-day moving average is $0.12.

About BetterLife Pharma

BetterLife Pharma Inc is a Canadian biotechnology company focused on developing novel treatments for mental health and neurological conditions. Its research programs are centered on pharmaceutical compounds derived from or inspired by psychedelic substances, with the goal of creating therapies that may offer therapeutic benefits without the hallucinogenic effects associated with some traditional psychedelics.

The company’s development programs have included BETR-001, a synthetic derivative of lysergic acid diethylamide (LSD) being studied for potential applications in depression and other neuropsychiatric disorders, and BETR-002, an ibogaine-derived compound being investigated for substance-use disorders and related conditions.